Clinical Trial Update: MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study [Phase 4]

View source ↗

Summary

Phase 4 prospective multicenter study MACT evaluating mono antiplatelet therapy with colchicine in acute coronary syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: CHA University | Conditions: Acute Coronary Syndrome | Phase 4 | Status: RECRUITING